The Ofichem Group is a distinguished organisation dedicated to the manufacture, development, and distribution of active pharmaceutical ingredients (APIs) for both the veterinary and human markets. Operating as a Contract Development and Manufacturing Organisation (CDMO), Ofichem collaborates closely with pharmaceutical producers around the globe, ensuring that their products meet the stringent requirements of Good Manufacturing Practices (GMP). The company possesses its own laboratory, which not only analyses the APIs produced in-house but also offers analytical services for external clients. Comprised of a small molecule drug substance CDMO Lab Ofichem, an oral solid dose drug product CDMO, Ofimedicine, and distribution organisations Ofichem BV and Ofipharma, this family-owned Dutch enterprise continually strives for innovation in the pharmaceutical sector.

Services include:
- Small Molecule, Drug Substance Manufacturing (API)
- Drug Product Formulation (FDF)
- Research & Development
- Packaging
- Regulatory Services
- Analytical Methods Development
- Containment
- APIs (Active Pharmaceutical Ingredients)
- Analytical Services
- Biologics

In conclusion, Ofichem is committed to providing top-tier services to the pharmaceutical industry, ensuring quality and compliance in every aspect of their operations. For more information, please visit ofichem.com.